Aileron Therapeutics Inc (NASDAQ:ALRN)
| 1.38 Delayed Data As of Mar 17 |  -0.10 / -6.67%Today’s Change | 1.25 Today|||52-Week Range 15.00 | -41.77% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Quarter Trend | |||||
|---|---|---|---|---|---|---|
| Quarter 3 2018 | Quarter 4 2018 | Quarter 1 2019 | Quarter 2 2019 | |||
| Revenue and Income | Net Revenues | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Depreciation And Amortization | 87.0K | 49.0K | 31.0K | 27.0K | ||
| Operating Expenses | Gross Income | -87.0K | -49.0K | -31.0K | -27.0K | |
| General Expenses | 7.4M | 6.9M | 7.3M | 7.4M | ||
| Research And Development | 4.3M | 4.0M | 4.2M | 4.3M | ||
| Total Operating Expenses | 7.5M | 7.0M | 7.3M | 7.4M | ||
| Non-Operating Expenses | Operating Income | -7.5M | -7.0M | -7.3M | -7.4M | |
| Interest Expense On Debt | 0.00 | 52.0K | 0.00 | 0.00 | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -7.4M | -7.0M | -7.2M | -7.2M | |
| Net Income | -7.4M | -7.0M | -7.2M | -7.2M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 14.7M | 14.7M | 14.8M | 26.5M | |
| Shares To Calculate EPS Diluted | 14.7M | 14.7M | 14.8M | 26.5M | ||
| Earnings Per Share | EPS | -$0.50 | -$0.48 | -$0.49 | -$0.26 | |
| EPS Diluted | -$0.50 | -$0.48 | -$0.49 | -$0.27 | ||
